Antiviral Research 47 (2000) 223 – 225
Subject index
Volume 47 (2000)
Acyclovir (ACV); Anti-HIV activity; Anti-HSV activity; Hu-man macrophages; (R)PMPA 47, 149
Acyclovir resistant; Pathogenesis; Genital herpes; Animal mod-els 47, 159
Adenovirus; Antiviral; ddC; Pneumonia model in mouse 47, 79
Adipogenesis; HIV; Protease inhibitors; Lipolysis; Lipodystro-phy 47, 121
AG7088; Human rhinovirus; Pleconaril; Protease inhibitors; Capsid binding agents 47, 217
Animal models; Pathogenesis; Acyclovir resistant; Genital her-pes 47, 159
Antibodies; Monoclonal antibodies; Antiviral; Immune globu-lin; Therapy; Prophylaxis 47, 57
Antifolate; Cytomegalovirus; Thymidylate synthase; ZD1694; Ganciclovir 47, 111
Anti-HIV activity; Acyclovir (ACV); Anti-HSV activity; Hu-man macrophages; (R)PMPA 47, 149
Anti-HSV activity; Acyclovir (ACV); Anti-HIV activity; Hu-man macrophages; (R)PMPA 47, 149
Antiretroviral treatment; HIV; Plasma infectivity; Plasma viral load 47, 189
Antiviral; Adenovirus; ddC; Pneumonia model in mouse 47, 79
Antiviral; Antibodies; Monoclonal antibodies; Immune globu-lin; Therapy; Prophylaxis 47, 57
Antiviral; Cidofovir; Cowpox virus; Intranasal treatment 47, 171
Antiviral; Cytomegalovirus; CHPMPC; Guinea pig; Immune compromised 47, 103
Antiviral therapy; Protease inhibitor; Mutations; Protease gene; Resistance; HIV 47, 179
Anti virus; CMV promoter; Zinc; DTPA; Metallothionein 47, 207
Capsid binding agents; Human rhinovirus; AG7088; Pleconaril; Protease inhibitors 47, 217
Cell culture infectious dose; RSV infections; NMSO3 47, 41
CHPMPC; Cytomegalovirus; Antiviral; Guinea pig; Immune compromised 47, 103
Cidofovir; Antiviral; Cowpox virus; Intranasal treatment 47, 171
CMV promoter; Anti virus; Zinc; DTPA; Metallothionein 47, 207
Cowpox virus; Antiviral; Cidofovir; Intranasal treatment 47, 171
Cytomegalovirus; CHPMPC; Antiviral; Guinea pig; Immune compromised 47, 103
Cytomegalovirus; Thymidylate synthase; Antifolate; ZD1694; Ganciclovir 47, 111
ddC; Adenovirus; Antiviral; Pneumonia model in mouse 47, 79
DTPA; CMV promoter; Anti virus; Zinc; Metalloth-ionein 47, 207
E6AP; HPV; ELISA 47, 199
ELISA; HPV; E6AP 47, 199
Subject index
224
Ganciclovir; Cytomegalovirus; Thymidylate synthase; Antifo-late; ZD1694 47, 111
Genital herpes; Pathogenesis; Acyclovir resistant; Animal mod-els 47, 159
Glycosylation; Retinoic acid; Herpes simplex virus 47, 29
Guinea pig; Cytomegalovirus; CHPMPC; Antiviral; Immune compromised 47, 103
Herpes simplex virus; Retinoic acid; Glycosylation 47, 29
Histoculture; Nuclear import inhibitor; Lymphoid tissue; Re-verse transcriptase 47, 89
HIV; Plasma infectivity; Plasma viral load; Antiretroviral treatment 47, 189
HIV; Protease inhibitor; Antiviral therapy; Mutations; Protease gene; Resistance 47, 179
HIV; Protease inhibitors; Adipogenesis; Lipolysis; Lipodystro-phy 47, 121
HPV; E6AP; ELISA 47, 199
Human macrophages; Acyclovir (ACV); Anti-HIV activity; Anti-HSV activity; (R)PMPA 47, 149
Human papillomavirus;Larrea tridentata; Plant lignan 47, 19
Human rhinovirus; AG7088; Pleconaril; Protease inhibitors; Capsid binding agents 47, 217
IFN administration route; Murine IFN-b; Mouse hepatitis virus 47, 131
Immune compromised; Cytomegalovirus; CHPMPC; Antiviral; Guinea pig 47, 103
Immune globulin; Antibodies; Monoclonal antibodies; Antivi-ral; Therapy; Prophylaxis 47, 57
Influenza virus; Neuraminidase inhibitors; Resistance to neu-raminidase inhibitors 47, 1
Integrase inhibitors; Retroviruses; Resistance; Structure of inte-grases 47, 139
Intranasal treatment; Antiviral; Cidofovir; Cowpox virus 47, 171
Larrea tridentata; Plant lignan; Human papillomavirus 47, 19
b-L-AZTTP; WT HIV-1 RT; M184V HIV-1 RT, Chain
termi-nation 47, 97
Lipodystrophy; HIV; Protease inhibitors; Adipogenesis; Lipol-ysis 47, 121
Lipolysis; HIV; Protease inhibitors; Adipogenesis; Lipodystro-phy 47, 121
Lymphoid tissue; Nuclear import inhibitor; Histoculture; Re-verse transcriptase 47, 89
Metallothionein; CMV promoter; Anti virus; Zinc; DTPA 47, 207
Monoclonal antibodies; Antibodies; Antiviral; Immune globu-lin; Therapy; Prophylaxis 47, 57
Mouse hepatitis virus; Murine IFN-b; IFN administration route 47, 131
Murine IFN-b; Mouse hepatitis virus; IFN administration route 47, 131
Mutations; Protease inhibitor; Antiviral therapy; Protease gene; Resistance; HIV 47, 179
M184V HIV-1 RT, Chain termination;b-L-AZTTP; WT HIV-1 RT 47, 97
Neuraminidase inhibitors; Influenza virus; Resistance to neu-raminidase inhibitors 47, 1
NMSO3; Cell culture infectious dose; RSV infections 47, 41
Nuclear import inhibitor; Lymphoid tissue; Histoculture; Re-verse transcriptase 47, 89
Pathogenesis; Acyclovir resistant; Genital herpes; Animal models 47, 159
Plant lignan;Larrea tridentata; Human papillomavirus 47, 19
Plasma infectivity; HIV; Plasma viral load; Antiretroviral treatment 47, 189
Plasma viral load; HIV; Plasma infectivity; Antiretroviral treatment 47, 189
Pleconaril; Human rhinovirus; AG7088; Protease inhibitors; Capsid binding agents 47, 217
Pneumonia model in mouse; Adenovirus; Antiviral; ddC 47, 79
Prophylaxis; Antibodies; Monoclonal antibodies; Antiviral; Immune globulin; Therapy 47, 57
Protease gene; Protease inhibitor; Antiviral therapy; Muta-tions; Resistance; HIV 47, 179
Subject index 225
Protease inhibitors; HIV; Adipogenesis; Lipolysis; Lipodystro-phy 47, 121
Protease inhibitors; Human rhinovirus; AG7088; Pleconaril; Capsid binding agents 47, 217
Resistance; Protease inhibitor; Antiviral therapy; Mutations; Protease gene; HIV 47, 179
Resistance; Retroviruses; Integrase inhibitors; Structure of in-tegrases 47, 139
Resistance to neuraminidase inhibitors; Influenza virus; Neu-raminidase inhibitors 47, 1
Retinoic acid; Herpes simplex virus; Glycosylation 47, 29
Retroviruses; Integrase inhibitors; Resistance; Structure of in-tegrases 47, 139
Reverse transcriptase; Nuclear import inhibitor; Lymphoid tissue; Histoculture 47, 89
(R)PMPA; Acyclovir (ACV); Anti-HIV activity; Anti-HSV activity; Human macrophages 47, 149
RSV infections; Cell culture infectious dose; NMSO3 47, 41
Structure of integrases; Retroviruses; Integrase inhibitors; Re-sistance 47, 139
Therapy; Antibodies; Monoclonal antibodies; Antiviral; Im-mune globulin; Prophylaxis 47, 57
Thymidylate synthase; Cytomegalovirus; Antifolate; ZD1694; Ganciclovir 47, 111
WT HIV-1 RT;b-L-AZTTP; M184V HIV-1 RT, Chain termi-nation 47, 97
ZD1694; Cytomegalovirus; Thymidylate synthase; Antifolate; Ganciclovir 47, 111
